dpp 4 inhibitors vs glp 1 agonist Mechanism of action for GIP, GLP-1 analogues and DPP4 in The effect of DPP-4 inhibitors,
Description
Here are the approved uses for the four main GLP-1s: Mounjaro and Zepbound These are the two brands of tirzepatide

Mounjaro generally outperforms Ozempic in terms of A1C reduction and weight loss

Diabetic Retinopathy: Diabetic retinopathy is a complication of diabetes where high blood sugar levels damage the retinas blood vessels

Depending on the drug, Phase 3 can take one to four years

(Tell me in the comments #ObesityMedicine #GLP1 #WeightManagement #FDAApproval #ClinicalPharmacy #MedicationAccess #PublicHealth #HealthEquity #ThePublicHealthPharmacist To view or add a comment, sign in The FDA has granted expedited approval to Eli Lilly's new weight-loss pill, orforglipron (Foundayo), marking it as the second daily oral GLP-1 medication for obesity
Short-acting GLP-1RAs slow down stomach emptying more than long-acting ones [2]
